What is the Oxford-AstraZeneca vaccine?

AstraZeneca Covid-19 vaccine approved in the U.K.

How the Oxford-AstraZeneca Covid-19 Vaccine Works

astrazeneca oxford

Oxford-AstraZeneca COVID-19 vaccine

The highly anticipated Covid-19 vaccine developed by the Oxford University with the pharmaceutical company AstraZeneca has been approved for use in the UK by the British regulator, it’s a homegrown one this time.

The government has ordered 100 million doses by the end of March 2020.

Similar to both Pfizer and Moderna vaccines, the AstraZeneca vaccine, requires two doses to be given to patients, The second vaccine is required to be given twelve (12) weeks after the first dose.

Astrazneca Oxford

Inexpensive and Practical

Easy to store, the Oxford/AstraZeneca vaccine approved this week by the British regulator and became the first major COVID vaccine candidate to publish peer-reviewed efficacy results specially from phase III.

Read More


Between April and Nov, 2020, more than 11 600 voluntary, in participants who received two standard doses, vaccine efficacy was 62%, and in participants who received a low dose followed by a standard dose, efficacy was 90%

Read More


This new vaccine, approved by UK regulator, was developed by the University of Oxford with the British group AstraZeneca Plc.

Read More

Advantages of the Oxford-AstraZeneca vaccine

The Oxford-AstraZeneca vaccine is a «viral vector» vaccine, when the vaccine is injected into a patient, it manifests as a carrier another virus adapted to fight Coronavirus. It prompts the immune system to start making antibodies for to attack any covid-19 infection.

British pharma giant AstraZeneca announced that its Oxford-AstraZeneca vaccine (AZD1222), is 70 percent effective in protecting against the virus. This vaccine can be kept at refrigerator temperatures of 2 to 8 degrees Celsius.

Inexpensive, practical and easy to store, it has many advantages :

The AstraZeneca / Oxford vaccine has the majore advantage of being inexpensive at a maximum cost of $3 a dose (about 2.50 euros ), and easy to store.

Who will get the Oxford-AstraZeneca vaccine and when?

The UK has ordered 100 million doses of the Oxford-AstraZeneca vaccine, with the hope to about 100,000 doses will be received in the january 2021. AstraZeneca company signed deals to prepare at least 300 million doses for the U.S and more than 400 million for European Union members.

India approves Oxford-AstraZeneca Covid-19 vaccine

The Indian government has approved the Oxford/AstraZeneca Covid-19 vaccine for emergency use India, which has the highest number of infections after the U.S, it is the first vaccine to get approval in India.

More than 50 million doses of the Oxford-AstraZeneca vaccine have already been stockpiled by the Serum Institute of India (SII), the vaccination programme aims to reach 200 million people by early July 2021.